Cambridge Scientist Appointed Inaugural Jubilee Professor of the Indian Academy of Sciences
News Jun 29, 2012
The Indian Academy of Sciences, founded in 1934 by the Nobel Prize-winning physicist Sir C.V. Raman, celebrated its platinum jubilee in 2009.
The Council of the Academy has instituted the Jubilee Professorship in connection with this event.
The distinguishing feature of the Professorship will be to offer the holder an opportunity for interactions and exchanges with students, researchers and teachers in several parts of India, and not just in the major metropolises.
This is in light of Academy’s aims of promoting the progress and upholding the cause of science throughout the country.
Professor Venkitaraman holds the Ursula Zoellner Professorship of Cancer Research in the University of Cambridge and is the Director of the Medical Research Council’s Cancer Cell Unit there. He is known for his research on the causes and treatment of cancer.
Prof. Ajay Sood, President, Indian Academy of Sciences said: “I am delighted to have Prof. Ashok Venkitaraman as the first occupant of Jubilee Chair of the Academy. As envisaged in this professorship, I am sure that students, teachers and researchers will be inspired by their close interaction with Professor Venkitaraman at the different universities and colleges he will visit.”
Professor Venkitaraman said: “I am honoured to have been appointed the first Jubilee Professor of the Indian Academy of Sciences, and thank the Academy for this award. It has been very exciting for me to witness personally over the past few years the excellence of research in the biomedical sciences at several Indian institutions, and I look forward to extending my interactions with colleagues and students in India during the Jubilee Professorship.”
Possible Biomarker to Identify Who Would Benefit from ImmunotherapyNews
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. In a new study, researchers examined tissue samples from melanoma and ovarian cancer patients treated with immunotherapies and found a link between the percentage of antigen-presenting cells expressing PD-L1 and an objective clinical response to treatment.READ MORE
Fight Against Cancer: Drug Combination Helps Kickstart the Immune SystemNews
Scientists from King's College London have found a way to boost the immune system to help it fight back against cancer.
The breakthrough involves the first ever use of a combination of chemotherapy and a drug being trialled as a treatment for neonatal jaundice, that together help kick start the body's natural defences.
Researchers Zoom in on DNA Code Being Read in CellsNews
Scientists have unveiled incredible images of how the DNA code is read and interpreted – revealing new detail about one of the fundamental processes of life. The mechanism for reading DNA and decoding it to build proteins for their needs is common to all animals and plants, and is often hijacked by cancer. The discovery of exactly how the molecular mechanism works, could open up new approaches to cancer treatment.READ MORE